Piper Sandler raised the firm’s price target on Delek US (DK) to $47 from $39 and keeps a Neutral rating on the shares. The firm notes Q3 results have wrapped and margins remain impressively strong. And while Q3 results were solid, Piper sees Q4 shaping up even better, with capture tailwinds, demand resilient, and margins robust, despite throughput guides suggesting 2.4% increase year-over-year. In the end, the market is clearly tighter than anticipated, and the firm still sees it getting incrementally tighter in 2026, and the futures curve now agrees.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DK:
- Delek US price target raised to $36 from $28 at TD Cowen
- Delek US price target raised to $45 from $37 at Mizuho
- Delek US Holdings: Hold Rating Maintained Amid Improved Earnings and Future Uncertainties
- Delek US price target raised to $40 from $33 at Scotiabank
- Delek US price target raised to $53 from $43 at Wells Fargo